Procter & Gamble CEO gets options on 191,909 shares

The stock options carry a $143.95 exercise price, an October 1, 2029 exercise date and an October 1, 2036 expiration.

Rhea-AI Filing Summary

Procter & Gamble CEO Shailesh Jejurikar received 16,065 restricted stock units on October 1, 2026, under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, and a stock-option award covering 191,909 common shares. His reported direct common stock holdings after the RSU award were 55,391 shares. As of October 1, 2026, his reported indirect common stock holdings included 3,742 shares through a retirement plan trustee, 19,757 shares in Sankhya S Jejurikar Revocable Trust and 35,836 shares in Shailesh Jejurikar Trust.

Insider Trade Summary

Grant/Award: 207,974 shares

Grant/Award 5 txns

Insider Jejurikar Shailesh

Role Chairman, President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	191,909	$0.00	$0.00
Grant/Award	Common Stock F1	16,065	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 191,909 contracts (Direct); Common Stock — 55,390.9973 shares (Direct); Common Stock — 3,741.7415 shares (Indirect, By Retirement Plan Trustee); Common Stock — 19,757 shares (Indirect, Sankhya S Jejurikar Revocable Trust); Common Stock — 35,836 shares (Indirect, Shailesh Jejurikar Trust)

Footnotes (1)

1. F1. Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan.

Key Figures

Restricted stock units awarded: 16,065 shares Common shares covered by stock-option award: 191,909 shares Option exercise price: $143.95 per share +4 more

7 metrics

Restricted stock units awarded 16,065 shares October 1, 2026

Common shares covered by stock-option award 191,909 shares October 1, 2026

Option exercise price $143.95 per share Stock-option award

Direct common stock holdings after RSU award 55,391 shares As of October 1, 2026

Indirect common stock held through retirement plan trustee 3,742 shares As of October 1, 2026

Indirect common stock in Sankhya S Jejurikar Revocable Trust 19,757 shares As of October 1, 2026

Indirect common stock in Shailesh Jejurikar Trust 35,836 shares As of October 1, 2026

Key Terms

Restricted Stock Units, Stock Option (Right to Buy), Exercise price, Expiration date

4 terms

Restricted Stock Units financial

"Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

Exercise price financial

"The stock options carry a $143.95 exercise price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Expiration date financial

"an October 1, 2036 expiration"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock awards did PG CEO Shailesh Jejurikar receive?

Shailesh Jejurikar received 16,065 restricted stock units and an option award covering 191,909 common shares on October 1, 2026. The restricted stock units were awarded under The Procter & Gamble 2025 Stock and Incentive Compensation Plan.

When can PG CEO Shailesh Jejurikar exercise his options, and when do they expire?

The options have an exercise date of October 1, 2029 and an expiration date of October 1, 2036. Their exercise price is $143.95.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/05/2026 - 01:55 PM Accepted by SEC EDGAR 10/05/2026 - 01:55 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jejurikar Shailesh

(Last) (First) (Middle)

ONE PROCTER & GAMBLE PLAZA

(Street)

CINCINNATI OHIO 45202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PROCTER & GAMBLE Co [ PG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2026		A		16,065	A	$0(1)	55,390.9973	D
Common Stock								3,741.7415	I	By Retirement Plan Trustee
Common Stock								19,757	I	Sankhya S Jejurikar Revocable Trust
Common Stock								35,836	I	Shailesh Jejurikar Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$143.95	10/01/2026		A		191,909		10/01/2029	10/01/2036	Common Stock	191,909	$0	191,909	D

Explanation of Responses:

1. Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan.

	/s/ Jennifer DollardSmith, attorney-in-fact for Shailesh Jejurikar	10/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)